The stock sits under USD 1 with a small public float, and shares in that position can swing sharply on modest volume. Recent themes around AIData Centerpower may also be drawing interest to the company's energy software unit.
No single company announcement dated November 2, 2026 was identified. The pressure appears tied to a cluster of recent filings covering listing compliance, a reverse split and related-party share issuance.
The nearest company news is a release dated October 27, 2026, saying the first patient had been dosed in the Corventis trial. The shares are also trading well above the USD 7.93 placement price, which is about 20.8 percent higher (calculated).
A search of company press releases and regulatory filings for the period from late October to November 2, 2026 did not turn up a new announcement, offering, guidance change or compliance notice. ## What the latest company updates show
Roze AI Inc. (NASDAQ:RZAI) was up 8.91 percent at USD 7.21 in pre-market trading on November 2, 2026. The stock only began trading on theNasdaqCapital Market on September 29, 2026, through a direct listing rather than an underwritten offering.
In the absence of news, the move may reflect trading in a small-capitalization stock after a long decline. This is a measured rationale, not a confirmed cause.
Sangrix (NASDAQ:SGRX) was down 12.64 percent to USD 0.6408 in pre-market trading on November 2, 2026. The stock is aPenny Stockwith a very small market value.
On October 20, 2026 the company saidNasdaqhad granted it an additional 180-day period to regain compliance with the minimum bid price rule. Six days later, on October 26, 2026, it announced aMergerterm sheet.
Smart Logistics Global Limited (NASDAQ:SLGB) was up 8.85 percent at USD 0.3321 in pre-market trading on November 2, 2026. The shares have been unusually active since the company announced aNasdaqextension after the close on October 29, 2026.
With the shares trading well below USD 1, moves of a few percent represent fractions of a cent, and ordinary pre-market order imbalances can produce them. The decline should be read as price action rather than a reaction to confirmed news.